Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection

Journal of Virology

Volumn 85, Issue 1, 2011, Pages 208-216

  Singh, Ravesh ^a   Gaiha, Gaurav ^b   Werner, Lise ^c   McKim, Kevin ^b   Mlisana, Koleka ^c   Luban, Jeremy ^d   Walker, Bruce D ^a,b,e   Karim, Salim S Abdool ^c   Brass, Abraham L ^b   Ndung'u, Thumbi ^a,b,c   Williamson, Carolyn ^f   Morris, Lynn ^f   Gray, Clive ^f   Hide, Winston ^f   Van Loggerenberg, Francois ^f  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b HARVARD UNIVERSITY   (United States)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON; MESSENGER RNA; MYXOVIRUS RESISTANCE PROTEIN A; PROTEIN; TRIPARTITE MOTIF PROTEIN 22; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG;

ARTICLE; CD4 LYMPHOCYTE COUNT; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; INFECTION RISK; LEUKEMIA CELL LINE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIMARY INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INHIBITION; VIRUS LOAD; VIRUS PARTICLE; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CELL LINE; COHORT STUDIES; FEMALE; GTP-BINDING PROTEINS; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; JURKAT CELLS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; REPRESSOR PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 1; ORTHOMYXOVIRIDAE;

EID: 78650065600     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01810-10     Document Type: Article

References (46)

1. Asaoka, K., K. Ikeda, T. Hishinuma, K. Horie-Inoue, S. Takeda, and S. Inoue. 2005. A retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons. Biochem. Biophys. Res. Commun. 338:1950-1956.
2. Barr, S. D., J. R. Smiley, and F. D. Bushman. 2008. The interferon response inhibits HIV particle production by induction of TRIM22. PLoS Pathog. 4:e1000007.
3. Bouazzaoui, A., M. Kreutz, V. Eisert, N. Dinauer, A. Heinzelmann, S. Hallenberger, J. Strayle, R. Walker, H. Rubsamen-Waigmann, R. Andreesen, and H. von Briesen. 2006. Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages. Virology 356:79-94.
4. Brass, A. L., I. C. Huang, Y. Benita, S. P. John, M. N. Krishnan, E. M. Feeley, B. J. Ryan, J. L. Weyer, L. van der Weyden, E. Fikrig, D. J. Adams, R. J. Xavier, M. Farzan, and S. J. Elledge. 2009. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus. West Nile virus, and dengue virus. Cell 139:1243-1254.
5. Carthagena, L., A. Bergamaschi, J. M. Luna, A. David, P. D. Uchil, F. Margottin-Goguet, W. Mothes, U. Hazan, C. Transy, G. Pancino, and S. Nisole. 2009. Human TRIM gene expression in response to interferons. PLoS One 4:e4894.
6. Fensterl, V., and G. C. Sen. 2009. Interferons and viral infections. Biofactors 35:14-20.
7. Gack, M. U., Y. C. Shin, C. H. Joo, T. Urano, C. Liang, L. Sun, O. Takeuchi, S. Akira, Z. Chen, S. Inoue, and J. U. Jung. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916-920.
8. Gao, G., X. Guo, and S. P. Goff. 2002. Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science 297:1703-1706.
9. Goff, S. P. 2004. Genetic control of retrovirus susceptibility in mammalian cells. Annu. Rev. Genet. 38:61-85.
10. Goldschmidt, V., G. Bleiber, M. May, R. Martinez, M. Ortiz, and A. Telenti. 2006. Role of common human TRIM5alpha variants in HIV-1 disease progression. Retrovirology 3:54.
11. Hardy, G. A., S. F. Sieg, B. Rodriguez, W. Jiang, R. Asaad, M. M. Lederman, and C. V. Harding. 2009. Desensitization to type I interferon in HIV-1 infection correlates with markers of immune activation and disease progression. Blood 113:5497-5505.
12. Harrer, T., E. Harrer, S. A. Kalams, T. Elbeik, S. I. Staprans, M. B. Feinberg, Y. Cao, D. D. Ho, T. Yilma, A. M. Caliendo, R. P. Johnson, S. P. Buchbinder, and B. D. Walker. 1996. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res. Hum. Retroviruses 12:585-592.
13. Harris, R. S., and M. T. Liddament. 2004. Retroviral restriction by APOBEC proteins. Nat. Rev. Immunol. 4:868-877.
14. Hatziioannou, T., D. Perez-Caballero, A. Yang, S. Cowan, and P. D. Bieniasz. 2004. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc. Natl. Acad. Sci. U. S. A. 101:10774-10779.
15. Javanbakht, H., W. Yuan, D. F. Yeung, B. Song, F. Diaz-Griffero, Y. Li, X. Li, M. Stremlau, and J. Sodroski. 2006. Characterization of TRIM5alpha trimerization and its contribution to human immunodeficiency virus capsid binding. Virology 353:234-246. (Pubitemid 44308489)
16. Kamga, I., S. Kahi, L. Develioglu, M. Lichtner, C. Maranon, C. Deveau, L. Meyer, C. Goujard, P. Lebon, M. Sinet, and A. Hosmalin. 2005. Type I interferon production is profoundly and transiently impaired in primary HIV-1 infection. J. Infect. Dis. 192:303-310.
17. Koning, F. A., S. A. Otto, M. D. Hazenberg, L. Dekker, M. Prins, F. Miedema, and H. Schuitemaker. 2005. Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection. J. Immunol. 175:6117-6122.
18. Kootstra, N. A., M. Navis, C. Beugeling, K. A. van Dort, and H. Schuitemaker. 2007. The presence of the Trim5alpha escape mutation H87Q in the capsid of late stage HIV-1 variants is preceded by a prolonged asymptomatic infection phase. AIDS 21:2015-2023.
19. Lehmann, C., J. M. Harper, D. Taubert, P. Hartmann, G. Fatkenheuer, N. Jung, J. van Lunzen, H. J. Stellbrink, R. C. Gallo, and F. Romerio. 2008. Increased interferon alpha expression in circulating plasmacytoid dendritic cells of HIV-1-infected patients. J. Acquir. Immune Defic. Syndr. 48:522-530.
20. Lehmann, C., D. Taubert, N. Jung, G. Fatkenheuer, J. van Lunzen, P. Hartmann, and F. Romerio. 2009. Preferential upregulation of interferon-alpha subtype 2 expression in HIV-1 patients. AIDS Res. Hum. Retroviruses 25:577-581.
21. Mandl, J. N., A. P. Barry, T. H. Vanderford, N. Kozyr, R. Chavan, S. Klucking, F. J. Barrat, R. L. Coffman, S. I. Staprans, and M. B. Feinberg. 2008. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat. Med. 14:1077-1087.
22. Meroni, G., and G. Diez-Roux. 2005. TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. Bioessays 27:1147-1157.
23. Moffat, J., D. A. Grueneberg, X. Yang, S. Y. Kim, A. M. Kloepfer, G. Hinkle, B. Piqani, T. M. Eisenhaure, B. Luo, J. K. Grenier, A. E. Carpenter, S. Y. Foo, S. A. Stewart, B. R. Stockwell, N. Hacohen, W. C. Hahn, E. S. Lander, D. M. Sabatini, and D. E. Root. 2006. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124:1283-1298.
24. Mogensen, K. E., M. Lewerenz, J. Reboul, G. Lutfalla, and G. Uze. 1999. The type I interferon receptor: structure, function, and evolution of a family business. J. Interferon Cytokine Res. 19:1069-1098.
25. Nisole, S., J. P. Stoye, and A. Saib. 2005. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 3:799-808.
26. Obad, S., T. Olofsson, N. Mechti, U. Gullberg, and K. Drott. 2007. Regulation of the interferon-inducible p53 target gene TRIM22 (Staf50) in human T lymphocyte activation. J. Interferon Cytokine Res. 27:857-864. (Pubitemid 350036595)
27. Ozato, K., D. M. Shin, T. H. Chang, and H. C. Morse III. 2008. TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 8:849-860.
28. Perron, M. J., M. Stremlau, B. Song, W. Ulm, R. C. Mulligan, and J. Sodroski. 2004. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc. Natl. Acad. Sci. U. S. A. 101:11827-11832.
29. Rajsbaum, R., J. P. Stoye, and A. O'Garra. 2008. Type I interferon-dependent and -independent expression of tripartite motif proteins in immune cells. Eur. J. Immunol. 38:619-630.
30. Reymond, A., G. Meroni, A. Fantozzi, G. Merla, S. Cairo, L. Luzi, D. Riganelli, E. Zanaria, S. Messali, S. Cainarca, A. Guffanti, S. Minucci, P. G. Pelicci, and A. Ballabio. 2001. The tripartite motif family identifies cell compartments. EMBO J. 20:2140-2151.
31. Sadler, A. J., and B. R. Williams. 2008. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8:559-568.
32. Sakuma, R., A. A. Mael, and Y. Ikeda. 2007. Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells. J. Virol. 81:10201-10206. (Pubitemid 350067723)
33. Sawyer, S. L., L. I. Wu, M. Emerman, and H. S. Malik. 2005. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc. Natl. Acad. Sci. U. S. A. 102:2832-2837.
34. Sayah, D. M., E. Sokolskaja, L. Berthoux, and J. Luban. 2004. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430:569-573.
35. Sewram, S., R. Singh, E. Kormuth, L. Werner, K. Mlisana, S. S. Karim, and T. Ndung'u. 2009. Human TRIM5alpha expression levels and reduced susceptibility to HIV-1 infection. J. Infect. Dis. 199:1657-1663.
36. Speelmon, E. C., D. Livingston-Rosanoff, S. S. Li, Q. Vu, J. Bui, D. E. Geraghty, L. P. Zhao, and M. J. McElrath. 2006. Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection. J. Virol. 80:2463-2471.
37. Stremlau, M., C. M. Owens, M. J. Perron, M. Kiessling, P. Autissier, and J. Sodroski. 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427:848-853. (Pubitemid 38297747)
38. Tissot, C., S. A. Taviaux, S. Diriong, and N. Mechti. 1996. Localization of Staf50, a member of the Ring finger family, to 11p15 by fluorescence in situ hybridization. Genomics 34:151-153.
39. Towers, G. J. 2005. Control of viral infectivity by tripartite motif proteins. Hum. Gene Ther. 16:1125-1132.
40. Uchil, P. D., B. D. Quinlan, W. T. Chan, J. M. Luna, and W. Mothes. 2008. TRIM E3 ligases interfere with early and late stages of the retroviral life cycle. PLoS Pathog. 4:e16.
41. van Loggerenberg, F., K. Mlisana, C. Williamson, S. C. Auld, L. Morris, C. M. Gray, Q. A. Karim, A. Grobler, N. Barnabas, I. Iriogbe, and S. S. A. Karim. 2008. Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study. PLoS One 3:e1954.
42. van Manen, D., M. A. Rits, C. Beugeling, K. van Dort, H. Schuitemaker, and N. A. Kootstra. 2008. The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection. PLoS Pathog. 4:e18.
43. von Wussow, P., D. Jakschies, H. K. Hochkeppel, C. Fibich, L. Penner, and H. Deicher. 1990. The human intracellular Mx-homologous protein is specifically induced by type I interferons. Eur. J. Immunol. 20:2015-2019.
44. Wang, Y. J., X. Wang, H. Zhang, L. Zhou, S. Liu, D. L. Kolson, L. Song, L. Ye, and W. Z. Ho. 2009. Expression and regulation of antiviral protein APOBEC3G in human neuronal cells. J. Neuroimmunol. 206:14-21.
45. Woelk, C. H., F. Ottones, C. R. Plotkin, P. Du, C. D. Royer, S. E. Rought, J. Lozach, R. Sasik, R. S. Kornbluth, D. D. Richman, and J. Corbeil. 2004. Interferon gene expression following HIV type 1 infection of monocyte-derived macrophages. AIDS Res. Hum. Retroviruses 20:1210-1222.
46. Yap, M. W., S. Nisole, C. Lynch, and J. P. Stoye. 2004. Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc. Natl. Acad. Sci. U. S. A. 101:10786-10791.